Last updated on December 2019

Study of Tarloxotinib in Pts With NSCLC (EGFR Exon 20 Insertion HER2-activating Mutations) & Other Solid Tumors With NRG1/ERBB Gene Fusions


Brief description of study

Open-label, Phase 2, single treatment arm, 3 cohorts

Clinical Study Identifier: NCT03805841

Find a site near you

Start Over

Potential RAIN-701 Study Site

Hong Kong, Hong Kong
6.56miles
  Connect »

RAIN-701 Study Site

Hong Kong, Hong Kong
6.56miles
  Connect »